Brief: Lyell Immunopharma Q4 Net Income USD -191.935 Million
11/03/2025 20:05
Mar 11 (Reuters) - Lyell Immunopharma Q4 operating expenses USD 201.158 million. Q4 operating income USD -201.147 million Q4 revenue USD 11 thousand
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma